Cargando…

Smad7 Deficiency in Myeloid Cells Does Not Affect Liver Injury, Inflammation or Fibrosis after Chronic CCl(4) Exposure in Mice

Myeloid cells play an essential role in the maintenance of liver homeostasis, as well as the initiation and termination of innate and adaptive immune responses. In chronic hepatic inflammation, the production of transforming growth factor beta (TGF-β) is pivotal for scarring and fibrosis induction a...

Descripción completa

Detalles Bibliográficos
Autores principales: Unrau, Ludmilla, Endig, Jessica, Goltz, Diane, Sprezyna, Paulina, Ulrich, Hanna, Hagenstein, Julia, Geers, Bernd, Kaftan, Karina, Heukamp, Lukas Carl, Tiegs, Gisa, Diehl, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584252/
https://www.ncbi.nlm.nih.gov/pubmed/34769006
http://dx.doi.org/10.3390/ijms222111575
_version_ 1784597404716105728
author Unrau, Ludmilla
Endig, Jessica
Goltz, Diane
Sprezyna, Paulina
Ulrich, Hanna
Hagenstein, Julia
Geers, Bernd
Kaftan, Karina
Heukamp, Lukas Carl
Tiegs, Gisa
Diehl, Linda
author_facet Unrau, Ludmilla
Endig, Jessica
Goltz, Diane
Sprezyna, Paulina
Ulrich, Hanna
Hagenstein, Julia
Geers, Bernd
Kaftan, Karina
Heukamp, Lukas Carl
Tiegs, Gisa
Diehl, Linda
author_sort Unrau, Ludmilla
collection PubMed
description Myeloid cells play an essential role in the maintenance of liver homeostasis, as well as the initiation and termination of innate and adaptive immune responses. In chronic hepatic inflammation, the production of transforming growth factor beta (TGF-β) is pivotal for scarring and fibrosis induction and progression. TGF-β signalling is tightly regulated via the Smad protein family. Smad7 acts as an inhibitor of the TGF-β-signalling pathway, rendering cells that express high levels of it resistant to TGF-β-dependent signal transduction. In hepatocytes, the absence of Smad7 promotes liver fibrosis. Here, we examine whether Smad7 expression in myeloid cells affects the extent of liver inflammation, injury and fibrosis induction during chronic liver inflammation. Using the well-established model of chronic carbon tetrachloride (CCl(4))-mediated liver injury, we investigated the role of Smad7 in myeloid cells in LysM-Cre Smad(fl/fl) mice that harbour a myeloid-specific knock-down of Smad7. We found that the chronic application of CCl(4) induces severe liver injury, with elevated serum alanine transaminase (ALT)/aspartate transaminase (AST) levels, centrilobular and periportal necrosis and immune-cell infiltration. However, the myeloid-specific knock-down of Smad7 did not influence these and other parameters in the CCl(4)-treated animals. In summary, our results suggest that, during long-term application of CCl(4), Smad7 expression in myeloid cells and its potential effects on the TGF-β-signalling pathway are dispensable for regulating the extent of chronic liver injury and inflammation.
format Online
Article
Text
id pubmed-8584252
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85842522021-11-12 Smad7 Deficiency in Myeloid Cells Does Not Affect Liver Injury, Inflammation or Fibrosis after Chronic CCl(4) Exposure in Mice Unrau, Ludmilla Endig, Jessica Goltz, Diane Sprezyna, Paulina Ulrich, Hanna Hagenstein, Julia Geers, Bernd Kaftan, Karina Heukamp, Lukas Carl Tiegs, Gisa Diehl, Linda Int J Mol Sci Article Myeloid cells play an essential role in the maintenance of liver homeostasis, as well as the initiation and termination of innate and adaptive immune responses. In chronic hepatic inflammation, the production of transforming growth factor beta (TGF-β) is pivotal for scarring and fibrosis induction and progression. TGF-β signalling is tightly regulated via the Smad protein family. Smad7 acts as an inhibitor of the TGF-β-signalling pathway, rendering cells that express high levels of it resistant to TGF-β-dependent signal transduction. In hepatocytes, the absence of Smad7 promotes liver fibrosis. Here, we examine whether Smad7 expression in myeloid cells affects the extent of liver inflammation, injury and fibrosis induction during chronic liver inflammation. Using the well-established model of chronic carbon tetrachloride (CCl(4))-mediated liver injury, we investigated the role of Smad7 in myeloid cells in LysM-Cre Smad(fl/fl) mice that harbour a myeloid-specific knock-down of Smad7. We found that the chronic application of CCl(4) induces severe liver injury, with elevated serum alanine transaminase (ALT)/aspartate transaminase (AST) levels, centrilobular and periportal necrosis and immune-cell infiltration. However, the myeloid-specific knock-down of Smad7 did not influence these and other parameters in the CCl(4)-treated animals. In summary, our results suggest that, during long-term application of CCl(4), Smad7 expression in myeloid cells and its potential effects on the TGF-β-signalling pathway are dispensable for regulating the extent of chronic liver injury and inflammation. MDPI 2021-10-27 /pmc/articles/PMC8584252/ /pubmed/34769006 http://dx.doi.org/10.3390/ijms222111575 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Unrau, Ludmilla
Endig, Jessica
Goltz, Diane
Sprezyna, Paulina
Ulrich, Hanna
Hagenstein, Julia
Geers, Bernd
Kaftan, Karina
Heukamp, Lukas Carl
Tiegs, Gisa
Diehl, Linda
Smad7 Deficiency in Myeloid Cells Does Not Affect Liver Injury, Inflammation or Fibrosis after Chronic CCl(4) Exposure in Mice
title Smad7 Deficiency in Myeloid Cells Does Not Affect Liver Injury, Inflammation or Fibrosis after Chronic CCl(4) Exposure in Mice
title_full Smad7 Deficiency in Myeloid Cells Does Not Affect Liver Injury, Inflammation or Fibrosis after Chronic CCl(4) Exposure in Mice
title_fullStr Smad7 Deficiency in Myeloid Cells Does Not Affect Liver Injury, Inflammation or Fibrosis after Chronic CCl(4) Exposure in Mice
title_full_unstemmed Smad7 Deficiency in Myeloid Cells Does Not Affect Liver Injury, Inflammation or Fibrosis after Chronic CCl(4) Exposure in Mice
title_short Smad7 Deficiency in Myeloid Cells Does Not Affect Liver Injury, Inflammation or Fibrosis after Chronic CCl(4) Exposure in Mice
title_sort smad7 deficiency in myeloid cells does not affect liver injury, inflammation or fibrosis after chronic ccl(4) exposure in mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584252/
https://www.ncbi.nlm.nih.gov/pubmed/34769006
http://dx.doi.org/10.3390/ijms222111575
work_keys_str_mv AT unrauludmilla smad7deficiencyinmyeloidcellsdoesnotaffectliverinjuryinflammationorfibrosisafterchronicccl4exposureinmice
AT endigjessica smad7deficiencyinmyeloidcellsdoesnotaffectliverinjuryinflammationorfibrosisafterchronicccl4exposureinmice
AT goltzdiane smad7deficiencyinmyeloidcellsdoesnotaffectliverinjuryinflammationorfibrosisafterchronicccl4exposureinmice
AT sprezynapaulina smad7deficiencyinmyeloidcellsdoesnotaffectliverinjuryinflammationorfibrosisafterchronicccl4exposureinmice
AT ulrichhanna smad7deficiencyinmyeloidcellsdoesnotaffectliverinjuryinflammationorfibrosisafterchronicccl4exposureinmice
AT hagensteinjulia smad7deficiencyinmyeloidcellsdoesnotaffectliverinjuryinflammationorfibrosisafterchronicccl4exposureinmice
AT geersbernd smad7deficiencyinmyeloidcellsdoesnotaffectliverinjuryinflammationorfibrosisafterchronicccl4exposureinmice
AT kaftankarina smad7deficiencyinmyeloidcellsdoesnotaffectliverinjuryinflammationorfibrosisafterchronicccl4exposureinmice
AT heukamplukascarl smad7deficiencyinmyeloidcellsdoesnotaffectliverinjuryinflammationorfibrosisafterchronicccl4exposureinmice
AT tiegsgisa smad7deficiencyinmyeloidcellsdoesnotaffectliverinjuryinflammationorfibrosisafterchronicccl4exposureinmice
AT diehllinda smad7deficiencyinmyeloidcellsdoesnotaffectliverinjuryinflammationorfibrosisafterchronicccl4exposureinmice